Engene Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.79

+0.03 (+1.70%)

As of Aug 8, 1:50 AM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 10 56%

Hold 7 39%

Sell 1 6%

Price Target

Analyst Price Target +3,549.7% upside

Low Target $48.23

Average Target $65.33

High Target $96.03

Current Price $1.79

Current
$1.79

Target
$65.33

$48.23 $65.33 avg $96.03

Scenario Analysis

Bear Case

$48.23

2,594.4%

Low target

Base Case

$65.33

+3,549.7%

Avg target

Bull Case

$96.03

+5,264.8%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$12.25

-85.4% from high

52-Week Low

$1.40

+27.9% from low

Target vs 52W High

$65.33

+433.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%